What is reality...M theory vs Moores law creating real universe vs creating a virtual one
oh the places we will go. if only most of you had any idea. kotaku.com http://www.youtube.com http://www.youtube.comFrom:TheBadcop69Views:25 2ratingsTime:15:04More inPeople Blogs
See original here:
What is reality...M theory vs Moores law creating real universe vs creating a virtual one - Video
Stem Cells and the Future of Medicine - Larry Goldstein, Ph.D. at TEDxAmericasFinestCity
Dr. Goldstein is a Professor of Cellular and Molecular Medicine at the University of California, San Diego, School of Medicine. He received his BA degree in biology and genetics at UCSD and his Ph.D. degree in genetics from the University of Washington, Seattle. He did his postdoctoral work at the University of Colorado at Boulder and the Massachusetts Institute of Technology. Prior to moving to UCSD, he was Professor of Cellular and Developmental Biology at Harvard University.From:TEDxTalksViews:240 13ratingsTime:16:15More inScience Technology
Follow this link:
Stem Cells and the Future of Medicine - Larry Goldstein, Ph.D. at TEDxAmericasFinestCity - Video
Education Book Review: Systems Biology (Current Topics from the Encyclopedia of Molecular Cell Bi...
http://www.EducationBookMix.com This is the summary of Systems Biology (Current Topics from the Encyclopedia of Molecular Cell Biology and Molecular Medicine) by Robert A. Meyers.From:EducationBookReviewsViews:0 0ratingsTime:01:27More inEntertainment
See the article here:
CTMM Nieuwspoortdebat 9 okt 2012 small FINAL
CTMM Nieuwspoortdebat 9 oktober 2012: #39;Keuzes in de Gezondheidszorg #39; Topsectorenbeleid medische technologie een wassen neus Hoe houden we de gezondheidszorg betaalbaar, van hoogstaande kwaliteit en voor iedereen toegankelijk? Dat was het centrale thema van een debat dat CTMM (Center for Translational Molecular Medicine) 9 oktober in perscentrum Nieuwspoort organiseerde. Conclusie: de overheid moet veel meer geld investeren in het topsectorenbeleid rond medische technologie. "Want dat is nu pure window dressing", aldus Jan Raaijmakers, Vice President External Scientific Collaborations Europe van GlaxoSmithKline. Om nieuwe, kostbare geneesmiddelen en therapien te kunnen blijven aanbieden, is er een urgente behoefte om de effectiviteit daarvan beter te kunnen voorspellen, zo vonden de deelnemers aan het debat. Tegelijkertijd zijn nieuwe methoden om ziekten in een vroeger stadium op te sporen dringend gewenst. Zoals Tom Oostrom, directeur van de Nierstichting en voorzitter van de Samenwerkende Gezondheidsfondsen het verwoordde: "Vroegdiagnostiek werkt kostenbesparend. Als mensen eenmaal klachten hebben, vallen de ziektekosten veel hoger uit. Zo kost nierdialyse jaarlijks maar liefst 80.000 euro per patint." En hoogleraar Cardiologie Yigal Pinto (AMC): "Er is enorm veel te winnen als je eerder kunt ingrijpen." Meer investeren in medische innovatie is dus dringend gewenst, concludeerde onder andere Jan Raaijmakers. "Nu is het topsectorenbeleid voor de medische technologie een ...From:Marjoke op het WerkViews:51 0ratingsTime:06:08More inNews Politics
More:
Nobel Laureate Dr James Watson Speech
Lecture of Academic Excellence "From the Double Helix to the Curing of Cancer" at the Inauguration Ceremony of the Cyprus School of Molecular Medicine.From:CINGCSMMViews:177 4ratingsTime:01:01:08More inScience Technology
Excerpt from:
Cyprus School of Molecular Medicine
The Dean of the Cyprus School of Molecular Medicine, Professor Leonidas Phylactou, speaks to CyBC news show Apo Mera se Mera about the newly established School of the Cyprus Institute of Neurology and Genetics.From:CINGCSMMViews:48 0ratingsTime:04:42More inScience Technology
See original here:
Cyprus School of Molecular Medicine - Press Conference March 2012
News feature on MEGA channel about the Cyprus School of Molecular Medicine, a school of the Cyprus Institute of Neurology and Genetics.From:CINGCSMMViews:52 2ratingsTime:01:45More inScience Technology
Originally posted here:
Cyprus School of Molecular Medicine - Press Conference March 2012 - Video
Blewitt ME (2011): Epigenetics and Cancer
Walter and Eliza Hall Institute Postgraduate lecture: 18 April 2011 Dr Marnie Blewitt Laboratory Head Molecular Medicine Walter and Eliza Hall InstituteFrom:WalterandElizaHallViews:1 0ratingsTime:53:20More inScience Technology
View original post here:
Prof Philippos Patsalis Inauguration Speech
Professor Philippos Patsalis speech at the Inauguration Ceremony of the Cyprus School of Molecular Medicine on Wednesday 17th October 2012.From:CINGCSMMViews:16 0ratingsTime:17:15More inScience Technology
Continued here:
RNA Replication For Biginners in Molecular Medicine By Ngenja Bidii
RNA synthesis in Eukaryote s involve 3 stages which include; intiation,elongation and termination.During Intiation of transcription,RNA-polymerase iii with the three sub-unit known as holo-enzyme binds to the promoter site which is mostly the TATA box.Successfully binding is followed by elongation process which involve addition of dNTPs as catalysed by core-enzyme.A core -enzyme is just a holo-enzyme lacking the sigma sub-unit. Upon reach of termination signal the synthesis is terminated.The termination signal is usually palindromic in sequencei.e can be read same from both directons.That how the synthesis occurs in brief.Am preparing for much details in my next video.Keep checking f0r updates.From:NgejaBidiiViews:1 0ratingsTime:04:41More inEducation
Continue reading here:
RNA Replication For Biginners in Molecular Medicine By Ngenja Bidii - Video
18 Molecular Medicine mdash;Genetic Screening
From:jeffrey727Views:0 0ratingsTime:30:38More inEducation
Go here to read the rest:
19 Molecular Medicine mdash;The Immune System
From:jeffrey727Views:0 0ratingsTime:29:20More inEducation
More:
20 Molecular Medicine mdash;Cancer
From:jeffrey727Views:0 0ratingsTime:30:29More inEducation
Read the original post:
22 Molecular Medicine mdash;Cloning and Stem Cells
From:jeffrey727Views:0 0ratingsTime:30:56More inEducation
See the rest here:
Coast to Coast AM - Oct 02 2012 - Space Travel Creature Forensics C2CAM
Date: 10-02-12 Host: George Noory Guests: William Louis McDonald , LA Marzulli Appearing during the middle two hours, forensic artist and alternative investigator, Bill McDonald, shared updates on several of his projects including the biology of the Loch Ness monster, as well as how advances in molecular medicine and nanotechnology will facilitate future long distance space travel beyond the orbit of Mars. Biological beings cannot survive deep space travels or warp drive, as they will acquire brittle bone disease and irreversible tissue damage, he said. So, one solution, he detailed, is using applied nanotechnology, which is to say loading millions of microscopic nano-assemblers, microsurgical bots and nanites with default medical support programming into each individual space traveler. Such technology would in effect turn the astronauts into cybernetic organisms or cyborgs, he noted. This correlates with reports of certain #39;Grey #39; ETs who #39;ve been described as being partly robotic, as well descriptions of the Roswell craft and aliens, in which the vehicle and flight crew were said to be merged into a "combined being," McDonald cited. Regarding his research into Nessie and sea monsters, he posited that certain types of eels could occasionally produce a single rare individual that is truly a giant aquatic monster, feeding both in the water and crawling around on land (see related illustration below). He correlated his theory to the work of Jeremy Wade of the River Monsters ...From:C2CPlanetViews:101 2ratingsTime:02:30:01More inEducation
More here:
Dra Joan Steitz Boyer Center for Molecular Medicine ingles
From:Multimedios-UAZ UAZViews:0 0ratingsTime:01:28:24More inScience Technology
More here:
Dra Joan Steitz Boyer Center for Molecular Medicine ingles - Video
Coast To Coast AM Space Travel Creature Forensics October 02 2012
WATCH THE LATEST VIDEO THAT CAME OUT TODAY HERE http://www.youtube.com http://www.jetstreamnews.com If You Use Twitter heres the Twitter address or just click the twitter link on the right of the channel page twitter.com Date: 10-02-12 Host: George Noory Guests: William Louis McDonald , LA Marzulli Appearing during the middle two hours, forensic artist and alternative investigator, Bill McDonald, shared updates on several of his projects including the biology of the Loch Ness monster, as well as how advances in molecular medicine and nanotechnology will facilitate future long distance space travel beyond the orbit of Mars. Biological beings cannot survive deep space travels or warp drive, as they will acquire brittle bone disease and irreversible tissue damage, he said. So, one solution, he detailed, is using applied nanotechnology, which is to say loading millions of microscopic nano-assemblers, microsurgical bots and nanites with default medical support programming into each individual space traveler. Such technology would in effect turn the astronauts into cybernetic organisms or cyborgs, he noted. This correlates with reports of certain #39;Grey #39; ETs who #39;ve been described as being partly robotic, as well descriptions of the Roswell craft and aliens, in which the vehicle and flight crew were said to be merged into a "combined being," McDonald cited. Regarding his research into Nessie and sea monsters, he posited that certain types of eels could occasionally produce a single rare ...From:USAMOONBASEViews:48 0ratingsTime:02:30:30More inEducation
Read the original here:
Nitric Oxide is The Most Important Molecule
Dr Nathan Bryan, Professor of Molecular Medicine explains how Nitric Oxide is the most important molecule produced by your blood vessels. As we age our body loses its ability to make Nitric Oxide. Research has shown that its that event that early event the inability to make Nitric Oxide that puts our body at risk to developing cardiovascular disease.From:John ThompsonViews:2 0ratingsTime:00:32More inEducation
Go here to read the rest:
BUSINESS WIRE: The 2nd meeting of the series Days of Molecular Medicine
25.10.2012, 10:00:06
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.
The Translational Science of Rare Diseases : From Rare to Care
PARIS --(BUSINESS WIRE)-- 25.10.2012 --
Each year the American Association for the Advancement of Science, which publishes the prestigious journals Science and Science Translational Medicine, the Karolinska institute in Stockholm, the DMMGF foundation and the Fondation Ipsen organise a series of meetings entitled Days of Molecular Medicine. This year the Institute for Molecular Biotechnology (Vienna) was also involved in the partnership. The meetings are highly regarded in the field of translational medicine, which bridges the gap between fundamental research and medical application. The latest event took place from 8-10 October in Vienna, Austria. Several well known scientists, including the Nobel Prize Eric Kandel attended the meeting.
Entitled "The translational science of rare diseases: Rare for Care", the meeting focused on an original topic with far-reaching consequences: research into rare illnesses and how it can lead to discovering therapies, including for common illnesses. Rare illnesses are also known as orphan diseases because they affect few patients and can therefore be neglected. Yet, although each rare illness only affects a few patients, together, they affect a lot of people. Their treatment also plays an essential role in adapting our approach to human physiology and pathology. Many rare illnesses have genetic origins that can be elucidated. Pinpointing the gene or genes involved enables a protein or a biochemical path to be targeted and acted on, using gene therapy or drugs. Cystic fibrosis is a remarkable example of this. Many pathogenic mutations have been identified and their mechanism brought to light through research into the disease. As Peter Mueller (Cambridge, USA) demonstrated in Vienna, this resulted in a drug formulation that can increase a patient's life expectancy by twenty years!
Concerning gene therapy, Alain Fischer (Hpital Necker, Paris, France) presented his pioneering work, while several others presented on-going trials to treat Canavan disease or blindness. Many extremely rare and newly identified illnesses were also presented, among them those discovered through a special programme instigated by the American National Institute of Health.
About the Fondation Ipsen
Established in 1983 under the aegis of the Fondation de France, the mission of the Fondation Ipsen is to contribute to the development and dissemination of scientific knowledge. The long-standing action of the Fondation Ipsen aims at fostering the interaction between researchers and clinical practitioners, which is indispensable due to the extreme specialisation of these professions. The ambition of the Fondation Ipsen is to initiate a reflection about the major scientific issues of the forthcoming years. It has developed an important international network of scientific experts who meet regularly at meetings known as Colloques Mdecine et Recherche, dedicated to six main themes: Alzheimer's disease, neurosciences, longevity, endocrinology, the vascular system and cancer science. Moreover the Fondation Ipsen has started since 2007 several meetings in partnership with the Salk Institute, the Karolinska Institutet, the Massachusetts General Hospital, the Days of Molecular Medicine Global Foundation as well as with the science journals Nature, Cell and Science. The Fondation Ipsen produced several hundreds publications; more than 250 scientists and biomedical researchers have been awarded prizes and research grants.
Read more here:
BUSINESS WIRE: The 2nd meeting of the series Days of Molecular Medicine
PARIS--(BUSINESS WIRE)--
Each year the American Association for the Advancement of Science, which publishes the prestigious journals Science and Science Translational Medicine, the Karolinska institute in Stockholm, the DMMGF foundation and the Fondation Ipsen organise a series of meetings entitled Days of Molecular Medicine. This year the Institute for Molecular Biotechnology (Vienna) was also involved in the partnership. The meetings are highly regarded in the field of translational medicine, which bridges the gap between fundamental research and medical application. The latest event took place from 8-10 October in Vienna, Austria. Several well known scientists, including the Nobel Prize Eric Kandel attended the meeting.
Entitled The translational science of rare diseases: Rare for Care, the meeting focused on an original topic with far-reaching consequences: research into rare illnesses and how it can lead to discovering therapies, including for common illnesses. Rare illnesses are also known as orphan diseases because they affect few patients and can therefore be neglected. Yet, although each rare illness only affects a few patients, together, they affect a lot of people. Their treatment also plays an essential role in adapting our approach to human physiology and pathology. Many rare illnesses have genetic origins that can be elucidated. Pinpointing the gene or genes involved enables a protein or a biochemical path to be targeted and acted on, using gene therapy or drugs. Cystic fibrosis is a remarkable example of this. Many pathogenic mutations have been identified and their mechanism brought to light through research into the disease. As Peter Mueller (Cambridge, USA) demonstrated in Vienna, this resulted in a drug formulation that can increase a patients life expectancy by twenty years!
Concerning gene therapy, Alain Fischer (Hpital Necker, Paris, France) presented his pioneering work, while several others presented on-going trials to treat Canavan disease or blindness. Many extremely rare and newly identified illnesses were also presented, among them those discovered through a special programme instigated by the American National Institute of Health.
About the Fondation Ipsen
Established in 1983 under the aegis of the Fondation de France, the mission of the Fondation Ipsen is to contribute to the development and dissemination of scientific knowledge. The long-standing action of the Fondation Ipsen aims at fostering the interaction between researchers and clinical practitioners, which is indispensable due to the extreme specialisation of these professions. The ambition of the Fondation Ipsen is to initiate a reflection about the major scientific issues of the forthcoming years. It has developed an important international network of scientific experts who meet regularly at meetings known as Colloques Mdecine et Recherche, dedicated to six main themes: Alzheimer's disease, neurosciences, longevity, endocrinology, the vascular system and cancer science. Moreover the Fondation Ipsen has started since 2007 several meetings in partnership with the Salk Institute, the Karolinska Institutet, the Massachusetts General Hospital, the Days of Molecular Medicine Global Foundation as well as with the science journals Nature, Cell and Science. The Fondation Ipsen produced several hundreds publications; more than 250 scientists and biomedical researchers have been awarded prizes and research grants.
Go here to see the original: